Novartis to Buy Myricx Bio for Up to $1.5 Billion
Novartis NOVN -0.02%decrease; down pointing triangle said it agreed to pay up to $1.5 billion for Myricx Bio,…
Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study
Roche Holding shares fell after the company said a late-stage study for an experimental breast-cancer treatment missed its…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN -1.20%decrease; red down pointing triangle said it agreed to buy biotech company Excellergy for up to…
Novartis Earnings Hit by Generic Competition
Novartis NOVN 0.79%increase; green up pointing triangle reported a drop in earnings as generic competition for its top-selling…
Exclusive | Anthropic Adds Novartis CEO to Board
Anthropic has appointed Vas Narasimhan, chief executive of Swiss pharmaceutical company Novartis NOVN 0.56%increase; green up pointing triangle,…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN 1.69%increase; green up pointing triangle said it agreed to buy biotech company Excellergy for up to…